Table 5.
Exon 4 intensity | Exon 4 % | OPN-c intensity | OPN-c % | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Treatment | n | Odds ratio | 95 % CI | p-value | Supre-mum test | Odds ratio | 95 % CI | p-value | Supre-mum test | Odds ratio | 95 % CI | p-value | Supre-mum test | Odds ratio | 95 % CI | p-value | Supre-mum test |
hormone no (all subgroups) | 54 | 0.503 | 0.287-0.881 | 0.016 | 0.104 | 1.087 | 0.624-1.895 | 0.767 | 0.908 | 0.620 | 0.353-1.089 | 0.096 | 0.178 | 1.210 | 0.696-2.102 | 0.500 | 0.954 |
hormone yes (all subgroups) | 65 | 0.657 | 0.381-1.134 | 0.131 | <.0001 | 0.687 | 0.391-1.206 | 0.191 | 0.056 | 0.826 | 0.463-1.473 | 0.517 | 0.005 | 1.101 | 0.630-1.923 | 0.735 | 0.704 |
hormone alone | 18 | 1.534 | 0.430-5.467 | 0.509 | 0.614 | 1.122 | 0.420-2.998 | 0.819 | 0.616 | 1.661 | 0.607-4.542 | 0.323 | 0.518 | 1.113 | 0.383-3.235 | 0.845 | 0.607 |
hormone and chemo | 16 | 0.412 | 0.129-1.316 | 0.134 | 0.022 | 0.637 | 0.173-2.343 | 0.497 | 0.064 | 0.634 | 0.204-1.973 | 0.432 | 0.049 | 1.352 | 0.441-4.148 | 0.598 | 0.269 |
hormone and radiation | 10 | 0.358 | 0.069-1.862 | 0.222 | 0.180 | 0.495 | 0.096-2.558 | 0.401 | 0.568 | 0.250 | 0.029-2.180 | 0.209 | 0.185 | 0.827 | 0.192-3.561 | 0.798 | 0.597 |
hormone, chemo, radiation | 21 | 0.598 | 0.169-2.112 | 0.424 | 0.763 | 0.604 | 0.218-1.676 | 0.333 | 0.801 | 0.867 | 0.278-2.710 | 0.806 | 0.375 | 0.894 | 0.310-2.580 | 0.836 | 0.810 |
chemo no (all subgroups) | 30 | 0.711 | 0.320-1.580 | 0.403 | 0.025 | 0.794 | 0.366-1.722 | 0.560 | 0.233 | 0.903 | 0.391-2.084 | 0.811 | 0.134 | 0.978 | 0.425-2.254 | 0.959 | 0.612 |
chemo yes (all subgroups) | 89 | 0.582 | 0.371-0.913 | 0.019 | 0.001 | 0.873 | 0.552-1.383 | 0.564 | 0.520 | 0.694 | 0.439-1.098 | 0.119 | 0.003 | 1.181 | 0.754-1.848 | 0.468 | 0.327 |
chemo (CMF) | 55 | 0.524 | 0.290- 0.943 | 0.031 | 0.008 | 0.727 | 0.403-1.314 | 0.291 | 0.693 | 0.706 | 0.391-1.276 | 0.249 | 0.013 | 1.113 | 0.626-1.979 | 0.715 | 0.337 |
chemo (AC/CMF) | 34 | 0.688 | 0.338-1.400 | 0.302 | 0.144 | 1.252 | 0.596-2.632 | 0.553 | 0.543 | 0.681 | 0.329-1.410 | 0.301 | 0.121 | 1.280 | 0.608-2.694 | 0.515 | 0.727 |
chemo alone | 13 | 0.418 | 0.111-1.574 | 0.197 | 0.763 | 1.207 | 0.367-3.971 | 0.757 | 0.637 | 0.711 | 0.205-2.468 | 0.592 | 0.047 | 1.200 | 0.362-3.980 | 0.766 | 0.560 |
chemo and radiation | 39 | 0.546 | 0.285-1.047 | 0.069 | 0.027 | 1.343 | 0.686-2.629 | 0.389 | 0.449 | 0.623 | 0.320-1.213 | 0.164 | 0.444 | 1.215 | 0.641-2.304 | 0.551 | 0.950 |
radiation no (all subgroups) | 47 | 0.647 | 0.333-1.259 | 0.200 | 0.024 | 0.973 | 0.519-1.824 | 0.933 | 0.203 | 0.981 | 0.527-1.826 | 0.951 | 0.105 | 1.400 | 0.746-2.627 | 0.294 | 0.404 |
radiation yes (all subgroups) | 72 | 0.626 | 0.376-1.044 | 0.073 | 0.002 | 0.774 | 0.466-1.285 | 0.321 | 0.489 | 0.675 | 0.394-1.157 | 0.153 | 0.036 | 1.086 | 0.659-1.791 | 0.745 | 0.832 |
Cox hazard ratios. The immunohistochemistry results for osteopontin-c and exon 4 were categorized into high staining (path scores 2 and 3) or low staining (path scores 0 and 1). Significant p-values are underlined, and confidence intervals that do not contain 1.0 are shown in bold. The last column displays the p-value for the supremum test, which assesses the proportionality assumption. p-values in italics are significant and indicate low confidence in the proportionality